Insider Trading & Ownership of Natalie McAndrew

Location
Malvern, PA
Signature
/s/ Steven Kelly, as Attorney-in-Fact for Natalie McAndrew
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Natalie McAndrew and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.

Quick Takeaways

  • Natalie McAndrew has 2 issuer positions tracked on this page.
  • Estimated disclosed ownership value is not available.
  • No recent insider transactions are currently listed.

What Changed

  • Largest disclosed position: Baudax Bio, Inc. ().
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Natalie McAndrew

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
BXRX Baudax Bio, Inc. Interim CFO 09 Oct 2023
CARM Carisma Therapeutics Inc. Vice President of Finance 01 Jan 2025

There are no insider transactions reported by Natalie McAndrew

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .